Delyla
Product Images NDC 51660-572

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Delyla (NDC 51660-572). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ohm Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Delylacarton (Delylacarton)

Packaging label for Delyla Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg by OHM LABORATORIES INC. The label shows the product name, active ingredients and strengths, dosage instructions, manufacturer information, NDC 51660-572-86, and package contents of one blister pack containing 28 tablets. The label has pink and white colors with barcode and regulatory information.*

FDA Label Image

Graph1 (Graph1)

Two line graphs showing the concentration of Levonorgestrel (left) and Ethinyl Estradiol (right) over time in hours. Each graph displays data points for Day 1, Day 6, and Day 21 with error bars, illustrating a decline in concentration levels from time zero up to approximately 72 hours.*

FDA Label Image

Graph2 (Graph2)

A bar chart showing data categorized by age groups (15-24, 25-34, 35-44, 45+), comparing four groups: ever-users (nonsmokers), controls (nonsmokers), ever-users (smokers), and controls (smokers). The y-axis represents frequency or count, with the highest value observed in the 45+ age group for ever-users (smokers).*

FDA Label Image

Levoblister1 (Levoblister1)

Delyla (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) blister card label showing a 4-week tablet schedule. The first three weeks contain active tablets, with the fourth week containing inert tablets. The label includes days of the week and directions for use with arrows, and states the product is manufactured by Haupt and is Rx only. NDC 51660-572-86 is visible on the label.*

FDA Label Image

Levoblister1__1 (Levoblister1 1)

A Delyla blister card label showing a 4-week cycle of Levonorgestrel and Ethinyl Estradiol tablets, USP 0.1 mg/0.02 mg. The card is organized by days of the week and weeks, with empty circles representing active tablets for weeks 1-3 and shaded circles for inert tablets in week 4. The label includes a start indicator at Sunday, and the manufacturer is noted as Haupt. The product NDC is 51660-572.*

FDA Label Image

Molformula1 (Molformula1)

Chemical structure diagram of Levonorgestrel, showing its molecular formula C21H28O2 and molecular weight 312.45. The diagram depicts the steroid framework with functional groups labeled, reflecting the active ingredient in the product Delyla by OHM Laboratories Inc.*

FDA Label Image

Molformula2 (Molformula2)

Chemical structure of Ethinyl Estradiol, illustrating the molecular formula C20H24O2 and molecular weight 296.4. The diagram shows a steroid backbone with hydroxyl groups and an alkyne substituent, representing the active ingredient in the product Delyla by OHM Laboratories Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.